(1553105) Changes in immune cell numbers and profile during long-term zanubrutinib treatment in treatment-naïve and relapsed/refractory patients with chronic lymphocytic leukemia

Primary Author; Presenting Author(s)

• MA

  Maria L. Andersson, MD

  Department of oncology-pathology, Karolinska Institutet, Stockholm, Sweden; Lymphoma Unit, Karolinska University Hospital
  Stockholm, Sweden

  Slides

Co-Author(s)

• TM

  Tom Mulder, MD, PhD

  Department of oncology-pathology, Karolinska Institutet
  Stockholm, Sweden
• KH

  Kia Heimersson, BMS

  BMA
  Department of oncology-pathology, Karolinska Institutet
  Stockholm, Stockholms Lan, Sweden
• SS

  Sonja Sönnert-Husa, N/A

  Center for clinical cancer studies, Karolinska University Hospital
  Stockholm, Sweden
• AG

  Annika Giertz, N/A

  Center for clinical cancer studies, Karolinska University Hospital
  Stockholm, Sweden
• CK

  Claes Karlsson, MD, PhD

  Department of oncology-pathology, Karolinska Institutet, Stockholm, Sweden; Lymphoma Unit, Karolinska University Hospital
  Stockholm, Sweden
• JL

  Jeanette Lundin, Assoc. Professor, MD, PhD

  Department of oncology-pathology, Karolinska Institutet, Stockholm, Sweden; Lymphoma Unit, Karolinska University Hospital
  Stockholm, Sweden
• LH

  Lotta Hansson, Assoc. Professor, MD, PhD

  Department of oncology-pathology, Karolinska Institutet, Stockholm, Sweden; Lymphoma Unit, Karolinska University Hospital
  Stockholm, Sweden
• AÃ

  Anders Österborg, Professor, MD, PhD

  Department of oncology-pathology, Karolinska Institutet, Stockholm, Sweden; Lymphoma Unit, Karolinska University Hospital
  Stockholm, Sweden
• MP

  Marzia Palma, MD, PhD

  Department of oncology-pathology, Karolinska Institutet, Stockholm, Sweden; Lymphoma Unit, Karolinska University Hospital
  Stockholm, Sweden